Endpoints News

Sanofi’s new CEO Belén Garijo gets frosty reception as challenges await
赛诺菲新任首席执行官贝伦•加里霍上任遭冷遇,挑战在前

The negative reaction to the impending departure of Sanofi CEO Paul Hudson, and Merck KGaA leader Belén Garijo as his replacement, is perhaps surprising given the French company’s muted performance under Hudson’s leadership.
鉴于赛诺菲在韩保罗(Paul Hudson)执掌期间表现平平,外界对赛诺菲首席执行官韩保罗即将离任、由默克集团(Merck KGaA)掌门人贝伦•加里霍(Belén Garijo)接任这一消息所引发的负面反应,或许有些出人意料。

本报道最初发表于Endpoints News。请点击这里查看原文

The negative reaction to the impending departure of Sanofi CEO Paul Hudson, and Merck KGaA leader Belén Garijo as his replacement, is perhaps surprising given the French company’s muted performance under Hudson’s leadership.

鉴于韩保罗(Paul Hudson)领导下赛诺菲(Sanofi)业绩平平,人们对其即将离任以及由默克集团(Merck KGaA)负责人贝伦•加里霍(Belén Garijo)接任所作出的负面反应或许令人意外。

您已阅读6%(360字),剩余94%(5716字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×